'Cll cohort 2' presentation slideshows

Next Generation TKIs and Small Molecule Inhibitors Jennifer R Brown, MD PhD Director, CLL Center

Next Generation TKIs and Small Molecule Inhibitors Jennifer R Brown, MD PhD Director, CLL Center Dana-Farber Cancer Institute Associate Professor of Medicine Harvard Medical School October 24, 2014. Targeting Kinases in the BCR Pathway. Everolimus. Dasatinib. Fostamatinib.

892 views • 43 slides